MQS Management LLC Makes New Investment in Dolby Laboratories $DLB

MQS Management LLC acquired a new position in shares of Dolby Laboratories (NYSE:DLB) in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 7,886 shares of the electronics maker’s stock, valued at approximately $586,000.

Other hedge funds also recently added to or reduced their stakes in the company. Cheviot Value Management LLC acquired a new position in Dolby Laboratories during the 1st quarter worth $27,000. MAI Capital Management lifted its position in shares of Dolby Laboratories by 87.1% in the 1st quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares during the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Dolby Laboratories in the 1st quarter worth about $29,000. Ameritas Advisory Services LLC bought a new position in shares of Dolby Laboratories in the 2nd quarter worth about $48,000. Finally, UMB Bank n.a. lifted its position in shares of Dolby Laboratories by 38.1% in the 2nd quarter. UMB Bank n.a. now owns 964 shares of the electronics maker’s stock worth $72,000 after buying an additional 266 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

Dolby Laboratories Trading Down 0.3%

DLB stock opened at $67.38 on Friday. Dolby Laboratories has a 52 week low of $66.96 and a 52 week high of $89.66. The company has a market capitalization of $6.46 billion, a price-to-earnings ratio of 24.68 and a beta of 0.92. The firm’s 50-day moving average is $71.40 and its two-hundred day moving average is $73.53.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, July 31st. The electronics maker reported $0.78 EPS for the quarter, topping analysts’ consensus estimates of $0.72 by $0.06. Dolby Laboratories had a net margin of 19.62% and a return on equity of 11.52%. The company had revenue of $315.55 million for the quarter, compared to the consensus estimate of $305.23 million. During the same period in the previous year, the firm earned $0.71 EPS. Dolby Laboratories’s revenue was up 9.2% on a year-over-year basis. Dolby Laboratories has set its FY 2025 guidance at 3.880-4.030 EPS. Q4 2025 guidance at 0.610-0.760 EPS. On average, equities research analysts predict that Dolby Laboratories will post 2.94 earnings per share for the current year.

Dolby Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, August 20th. Shareholders of record on Tuesday, August 12th were given a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Tuesday, August 12th. Dolby Laboratories’s payout ratio is 48.35%.

Insider Transactions at Dolby Laboratories

In other Dolby Laboratories news, CEO Kevin J. Yeaman sold 25,000 shares of the business’s stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total transaction of $1,721,750.00. Following the sale, the chief executive officer directly owned 114,725 shares in the company, valued at approximately $7,901,110.75. The trade was a 17.89% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Shriram Revankar sold 7,000 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total transaction of $524,440.00. Following the sale, the senior vice president owned 70,435 shares in the company, valued at $5,276,990.20. This trade represents a 9.04% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 82,000 shares of company stock worth $5,845,440 over the last 90 days. 38.39% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on DLB. Barrington Research restated an “outperform” rating and issued a $100.00 price target on shares of Dolby Laboratories in a research report on Friday, September 12th. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Rosenblatt Securities restated a “buy” rating and issued a $95.00 price target on shares of Dolby Laboratories in a research report on Friday, August 1st. Wall Street Zen upgraded shares of Dolby Laboratories from a “hold” rating to a “buy” rating in a research report on Saturday, August 30th. Finally, Robert W. Baird assumed coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They issued a “neutral” rating and a $74.00 price objective on the stock. Three analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $95.75.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.